In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antares Pharma, Inc.

http://www.antarespharma.com/

Latest From Antares Pharma, Inc.

China Deal Watch: Four Biotechs Kick Off May With Multiple In/Out Deals

Four Chinese biotech companies reach in- and out-licensing deals covering antibody drug conjugates, small molecules and vaccines as they continue to pursue and develop innovation.

China Deals

Beijing Expands COVID Testing; Stringent New COVID Policy Coming?

Beijing expands mass testing to more areas and Shanghai’s case fatally rate raises questions amid China deals with the worst outbreak in two years.

Coronavirus COVID-19 Policy

As Biotech M&A Activity Gingerly Rises, Regeneron Makes Moves On Checkmate

Regeneron hopes to bolster its immuno-oncology pipeline with the acquisition of Checkmate, which joins a spate of similar deals suggesting renewed interest in biotech investment despite an industry-wide slowdown.

M & A Deals

Halozyme Buys Antares, Expanding Drug Delivery Ambitions

Halozyme will pay $960m to acquire Antares, gaining an auto-injector drug delivery platform, which the company said has broad licensing potential, as well as a commercial portfolio.

Drug Delivery Technology Deals
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Topical Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • Medi-Ject Corporation
    • Permatec
UsernamePublicRestriction

Register